As of January 2026 BridgeBio Pharma has a market cap of โน1.335 Trillion. This makes BridgeBio Pharma the world's 1495th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 19th, 2026 the market cap of BridgeBio Pharma was reported to be: